Trial Profile
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2011
Price :
$35
*
At a glance
- Drugs MEDI 3414 (Primary) ; Influenza virus vaccine live
- Indications Influenza virus infections
- Focus Therapeutic Use
- 18 Aug 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 18 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Sep 2009 New trial record